Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)
China flag China · Delayed Price · Currency is CNY
13.57
+0.04 (0.30%)
Feb 27, 2026, 3:04 PM CST

SHE:002727 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
2,4323,4183,6763,5122,2351,624
Short-Term Investments
--219.66--1,433
Trading Asset Securities
765.04--8.36297.3-
Cash & Short-Term Investments
3,1973,4183,8953,5202,5323,057
Cash Growth
-1.20%-12.26%10.66%39.00%-17.16%27.91%
Accounts Receivable
1,7431,6131,5551,7761,376846.91
Other Receivables
317.5319.49313.3307.29206.63150.18
Receivables
2,0601,9321,8682,0831,583997.09
Inventory
3,6204,0883,8533,3873,3172,194
Prepaid Expenses
-3.491.030.140.160.01
Other Current Assets
268.4270.29275.63467.06260.12469.49
Total Current Assets
9,1469,7129,8939,4587,6926,718
Property, Plant & Equipment
3,5553,9563,9513,9944,080690.52
Long-Term Investments
147.92136.52143.26352.46107.2283.64
Goodwill
1,9831,9831,6501,3971,3801,102
Other Intangible Assets
221.29196.86178.08165.67122.89122.88
Long-Term Deferred Tax Assets
110.4893.788.9494.1158.4627.62
Long-Term Deferred Charges
648.85724.03661.17629.9590.75530.72
Other Long-Term Assets
28.162982.3188.59305.7152.71
Total Assets
15,84116,83016,64716,17914,3379,328
Accounts Payable
4,4924,9164,3394,3293,8062,876
Accrued Expenses
232.83539.54681.48518.75295.38328.78
Short-Term Debt
537.77495.57468.6402.57127.760.06
Current Portion of Long-Term Debt
907.99-1.80.24.02-
Current Portion of Leases
-1,005975.88932.771,012-
Current Income Taxes Payable
136.4753.6281.37197.86118.454.53
Current Unearned Revenue
106.82116.9113.72156.61105.1867.15
Other Current Liabilities
564.72504.61537.55339.23415.09145.71
Total Current Liabilities
6,9797,6317,2006,8775,8843,532
Long-Term Debt
114.81--1.835.08-
Long-Term Leases
1,2571,5311,5521,7571,729-
Long-Term Unearned Revenue
17.2811.5514.5412.1513.3415.79
Long-Term Deferred Tax Liabilities
3.473.553.934.053.56-
Total Liabilities
8,3719,1778,7708,6527,6653,548
Common Stock
585.6585.6596.01596.02596.18595.31
Additional Paid-In Capital
2,0132,0192,1442,1472,1572,097
Retained Earnings
4,8684,8865,0114,7003,8693,126
Treasury Stock
-150--4.24-22.69-46.86-53.37
Comprehensive Income & Other
---6.192.930.32
Total Common Equity
7,3177,4917,7467,4266,5785,765
Minority Interest
152.5162.27131.04101.4494.815.09
Shareholders' Equity
7,4707,6537,8777,5286,6735,780
Total Liabilities & Equity
15,84116,83016,64716,17914,3379,328
Total Debt
2,8173,0312,9983,0942,90860.06
Net Cash (Debt)
379.95386.58896.84425.94-375.582,997
Net Cash Growth
212.36%-56.90%110.56%--57.15%
Net Cash Per Share
0.650.651.500.72-0.635.23
Filing Date Shares Outstanding
574.13585.6596.01596.02596.18595.31
Total Common Shares Outstanding
574.13585.6596.01596.02596.18595.31
Working Capital
2,1672,0802,6932,5811,8093,186
Book Value Per Share
12.7412.7913.0012.4611.039.68
Tangible Book Value
5,1135,3115,9185,8635,0754,540
Tangible Book Value Per Share
8.919.079.939.848.517.63
Buildings
-892.7894.92785.07741.03576.73
Machinery
-447.47416.9385.35350.85293.68
Construction In Progress
-35.799.813.8725.4715.42
Source: S&P Global Market Intelligence. Standard template. Financial Sources.